Did You Know?

Editor’s Picks

Latest News

Dragonfleye Therapeutics Corp. Takes Flight, Raising US$37.5 Million in Private Placement Offerings to Advance Novel Ocular Platform-Based Treatments

TORONTO, ON / ACCESS Newswire / October 26, 2026 / Dragonfleye Therapeutics Corp. ("Dragonfleye" or the "Company"), a patient-centered, innovation-focused...

Ubiquitech Software Corp. (UBQU) Explores Strategic Merger Opportunities in the Growing Specialty Materials and Advanced Textile Manufacturing Industry

Management Identifies Potential Opportunities Within Global Synthetic Fiber Market, Projected to Reach $144 Billion by 2033Tampa, Florida--(Newsfile Corp. - October...

Arthritis Foundation and Founding Sponsor Zimmer Biomet Announce New Community Celebrating Life After Joint Replacement and Inspiring Others to Act on Severe Joint Pain

The Comeback Club connects people who have had joint replacement with those considering it.ATLANTA and WARSAW, Ind., Oct. 26, 2026...

MEDSIR presents final TUXEDO-3 results highlighting the potential of patritumab deruxtecan in active brain metastases and leptomeningeal disease

The TUXEDO-3 study evaluates the efficacy of patritumab deruxtecan (HER3-DXd) for treating active brain metastases in patients with metastatic breast...

Aptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplant

Ten patients initially deemed unfit for intensive chemotherapy proceeded to stem cell transplantTransplant rate compares favorably with historical standard-of-care experience,...

Hepion Pharmaceuticals Receives FDA Feedback Supporting a Path to Demonstrating Prophylactic Protection for GV104 Against Fentanyl-Induced Cardiac Arrest

error: Content is protected !!